Analyst Ratings for Intercept Pharmaceuticals (ICPT) [Sells]
ICPT Rating Summary
ICPT Price Target Summary
- Highest: $19.00 (RBC Capital)
- Lowest: $12.00 (Goldman Sachs)
- Average: $17.14
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$17.14 (-9.8%)
* Over Last 12-Mos
Rating Score: 3.9 / 10
Percentile Rank: 38%
Rating Score: 3.9 / 10
Percentile Rank: 38%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2021 | Goldman Sachs » Updated 5/17/2023 |
Salveen Richter | Downgrade | Sell (Neutral) |
12.00 (N/A) |
14.22 (19.00) |
33.61% | Details |
| 1/15/2021 | BofA Securities » Updated 8/7/2023 |
Geoff Meecham | Downgrade | Underperform (Neutral) |
13.00 (14.00) |
29.24 (19.00) |
-35.02% | Details |
 |
||||||||
